Survival rates for adult and pediatric patients with brain tumors have not changed significantly over the past 45 years despite major improvements made in the treatment of other cancers. Through NBTS’s DNA Damage Response Consortium, researchers like Erik Sulman, MD, PhD, at NYU Langone Health’s Perlmutter Cancer Center are working together across institutions to disrupt the status quo because breakthroughs can’t wait. | National Brain Tumor Society